2016
DOI: 10.1186/s40644-016-0081-5
|View full text |Cite
|
Sign up to set email alerts
|

Gallium-68 perfusion positron emission tomography/computed tomography to assess pulmonary function in lung cancer patients undergoing surgery

Abstract: BackgroundPre-operative evaluation of lung cancer patients relies on calculation of predicted post-operative (PPO) lung function based on split lung function testing. Pulmonary perfusion (Q) PET/CT can now be performed by substituting Technetium-99 m labeling of macroaggregated albumin (MAA) with Gallium-68. This study compares Q PET/CT with current recommended methods of pre-operative lung function assessment.MethodsTwenty-two patients planned for curative surgical resection (mean FEV1 77 %, SD 21 %; mean DLC… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
14
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 21 publications
(14 citation statements)
references
References 25 publications
0
14
0
Order By: Relevance
“…Our institution has been at the forefront of preoperative risk stratification for patients with lung cancer undergoing lung resection, reporting methods such as the predicted postoperative product as a predictor of surgical mortality [18]. We have previously reported perioperative risk stratification in various populations including after induction therapy [19] and using advanced molecular imaging technologies [20]. In the present case, we further attempt to more accurately stratify an individual patient's risk in order to clearly communicate and engage in informed and shared decision making.…”
Section: Discussionmentioning
confidence: 99%
“…Our institution has been at the forefront of preoperative risk stratification for patients with lung cancer undergoing lung resection, reporting methods such as the predicted postoperative product as a predictor of surgical mortality [18]. We have previously reported perioperative risk stratification in various populations including after induction therapy [19] and using advanced molecular imaging technologies [20]. In the present case, we further attempt to more accurately stratify an individual patient's risk in order to clearly communicate and engage in informed and shared decision making.…”
Section: Discussionmentioning
confidence: 99%
“…Several previous studies did not compare the scintigraphyderived results with actual postoperative lung function tests, and some evaluated only FEV1 as a measure of the patient's lung function (14,15,18,19,21). In this study, the predicted results (ppo-FEV1 and ppoDLCO) according to the different quantification methods were compared with the postoperative tests, which are considered the gold standard, in a subgroup of 60 patients.…”
Section: Discussionmentioning
confidence: 99%
“…Percentage lobar ventilation, perfusion, and CT volume, as a percentage of total lung values, were recorded, along with normal ventilation/perfusion, matched, and unmatched defects for each lobe. The sum of matched/unmatched defects and normal ventilation was equal to 100%, as previously described [8].…”
Section: Ga-vq/pet-ctmentioning
confidence: 99%
“…The use of gallium-68 ( 68 Ga) ventilation/perfusion (VQ) positron emission tomography (PET)-CT imaging for assessment of regional/lobar lung function, including visualization of changes following endobronchial valve insertion, has previously been reported [7,8]. This technique allows regional assessment of VQ at a sublobar anatomical level with superior resolution to planar VQ and single photon emission tomography (SPECT) VQ imaging [9,10].…”
Section: Introductionmentioning
confidence: 99%